BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8927326)

  • 1. [Studying the effect of enzyme replacement in chronic pancreatitis].
    Takács T; Tiszai A; Lonovics J
    Orv Hetil; 1996 May; 137(19):1033-6. PubMed ID: 8927326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorption of alpha-amylase (EC 3.2.1.1) and lipase (EC 3.1.1.3) before and after substitution therapy in exocrine pancreatic insufficiency.
    Gregar I; Kojecký Z; Matlocha Z
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():233-43. PubMed ID: 2977896
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality of life in the course of enzyme replacement therapy for chronic pancreatitis].
    Czakó L; Takács T; Lonovics J; Lakner L; Döbrönte Z; Prónai L; Tulassay Z
    Orv Hetil; 2002 Jun; 143(25):1521-7. PubMed ID: 12577405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation.
    Slaff JI; Wolfe MM; Toskes PP
    J Lab Clin Med; 1985 Mar; 105(3):282-5. PubMed ID: 3973464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
    Dobrilla G
    Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-specific suppression of pancreatic exocrine secretion.
    Slaff J; Jacobson D; Tillman CR; Curington C; Toskes P
    Gastroenterology; 1984 Jul; 87(1):44-52. PubMed ID: 6202586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of fecal elastase test in pancreatic exocrine deficiency].
    Czakó L; Takács T; Farkas G; Boda K; Lonovics J
    Orv Hetil; 1999 Aug; 140(34):1887-90. PubMed ID: 10502971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
    Kahl S; Schütte K; Glasbrenner B; Mayerle J; Simon P; Henniges F; Sander-Struckmeier S; Lerch MM; Malfertheiner P
    JOP; 2014 Mar; 15(2):165-74. PubMed ID: 24618443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B; Ivaldi AP
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis.
    Brown A; Hughes M; Tenner S; Banks PA
    Am J Gastroenterol; 1997 Nov; 92(11):2032-5. PubMed ID: 9362186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of Creon and Eurobiol in the treatment of exocrine pancreatic insufficiency in adults].
    Emerit J; Levy VG; Paris JC; Quinton A; Sarles H
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):263-7. PubMed ID: 3207353
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diarrhea caused by exocrine pancreatic insufficiency in adults].
    Bernades P
    Rev Prat; 1989 Dec; 39(29):2610-2. PubMed ID: 2602894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.
    Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
    Pancreatology; 2012; 12(1):71-3. PubMed ID: 22487479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the substitution therapy with pancreatic enzyme preparations].
    Goebell H; Bode C
    Med Welt; 1969 Apr; 20(15):877-84. PubMed ID: 5784374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Requirements for successful pancreatic enzyme replacement therapy (comparative study of Kreon and Panpur)].
    Pap A; Korom M; Marosi E; Varró V
    Orv Hetil; 1990 Feb; 131(5):241-4. PubMed ID: 2304764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid pancreatic enzyme therapy for a patient with short bowel syndrome and chronic pancreatitis in a complicated case of Crohn's disease.
    Hardt PD; Helfrich C; Klauke T; Klör HU
    Eur J Med Res; 1999 Aug; 4(8):345-6. PubMed ID: 10471547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzyme substitution in the treatment of pain in chronic pancreatitis. Significance of feedback regulation in pancreatic secretion].
    Adler G
    Dtsch Med Wochenschr; 1988 Jul; 113(26):1075-9. PubMed ID: 3289883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.